Genprex Inc.
Organization details
- Legal name
- Genprex Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Texas
- Headquarters city
- Austin
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- GNPX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001595248
- EIN
- 90-0772347
Board of directors
-
Brent M. Longnecker · DirectorSince 2023
-
John Rodney Varner · Director · Chairman, President and CEOSince 2023
-
Ryan M. Confer · Director · President, CEO and CFOSince 2024
-
Toscano Jose Antonio Moreno · DirectorSince 2023
-
William R. Wilson Jr. · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 18, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
83.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $22
- 2 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 14, 2026 | Brent M. Longnecker Director | Open-market sale | −8 | $1.23 | $10 |
| Apr 14, 2026 | Brent M. Longnecker Director | Open-market sale | −10 | $1.23 | $12 |
| Feb 27, 2026 | Berger Mark Stanley Officer (Chief Medical Officer) | Shares withheld for tax | −7,168 | $2.00 | $14,336 |
| Feb 27, 2026 | Ryan M. Confer Director, Officer (President, CEO and CFO) | Shares withheld for tax | −9,330 | $2.00 | $18,660 |
| Dec 22, 2025 | Toscano Jose Antonio Moreno Director | Grant or award | +9,000 | — | — |
| Dec 22, 2025 | Berger Mark Stanley Officer (Chief Medical Officer) | Grant or award | +28,500 | — | — |
| Dec 22, 2025 | Ryan M. Confer Director, Officer (President, CEO and CFO) | Grant or award | +45,000 | — | — |
| Dec 22, 2025 | Brent M. Longnecker Director | Grant or award | +9,000 | — | — |
| Dec 22, 2025 | William R. Wilson Jr. Director | Grant or award | +9,000 | — | — |
| Jun 30, 2025 | Berger Mark Stanley Officer (Chief Medical Officer) | Shares withheld for tax | −4,500 | $0.23 | $1,035 |
| Jun 30, 2025 | Ryan M. Confer Director, Officer (President, CEO and CFO) | Shares withheld for tax | −5,775 | $0.23 | $1,328 |
| Feb 18, 2025 | Berger Mark Stanley Officer (Chief Medical Officer) | Shares withheld for tax | −585 | $0.41 | $240 |
| Feb 18, 2025 | Ryan M. Confer Director, Officer (President, CEO and CFO) | Shares withheld for tax | −395 | $0.41 | $162 |
| Dec 5, 2024 | Toscano Jose Antonio Moreno Director | Grant or award | +4,750 | — | — |
| Dec 5, 2024 | William R. Wilson Jr. Director | Grant or award | +4,750 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Genprex Inc.
Who is the CEO of Genprex Inc.?
John Rodney Varner is Genprex Inc.'s President & CEO.
How many directors are on Genprex Inc.'s board?
Genprex Inc.'s board has 5 directors: Brent M. Longnecker, John Rodney Varner, Ryan M. Confer, Toscano Jose Antonio Moreno and William R. Wilson Jr.
Are Genprex Inc. insiders buying or selling shares?
Over the last 12 months, Genprex Inc. insiders made no open-market purchases and sold $22 of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="genprex-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.